Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
FDC Limited is a pharmaceutical company engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
1 month ago•Economic Times
1 month ago•Business Standard
1 month ago•Business Standard
FDC Limited has informed the Exchange regarding a press release dated August 08, 2024, titled "Press Release issued in relation to the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter ended June 30, 2024". | Download
FDC Limited has informed the Exchange regarding a press release dated August 08, 2024, titled "Press Release issued in relation to the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter ended June 30, 2024". | Download
Interim • Div/Share: ₹ 0.8
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant